Hovione

Hovione Opens New Facility, Doubling US Spray Drying Capacity

Milestone completes a $100 million investment cycle in New Jersey and supports Hovione’s long-term vision for a next-generation pharmaceutical development and manufacturing hub.

Hovione Names Stefan Doboczky New CEO

Stefan Doboczky to take over operational leadership of the family-owned pharmaceutical technology and services group on April 1, 2027.

Hovione Completes €40 Million Expansion of Loures Tablet Manufacturing Center

Expansion strengthens integrated manufacture of amorphous solid dispersions (ASDs) by spray drying and tableting at a single site, accelerating development and simplifying supply.

Hovione Completes $100 Million Investment to Expand Operations at US Manufacturing Site

Hovione has completed a $100 million investment to double spray-drying capacity and expand its East Windsor, New Jersey site, positioning the facility to meet growing US demand.

Hovione and Firstgene Announce Strategic Collaboration

Exclusive licensing and R&D collaboration between Hovione and Firstgene.

Hovione Expands Spray Drying Capacities in the USA and Ireland

Lisbon, Portugal-headquartered Hovione has completed significant expansions in Europe and the USA. The investments at the facilities in East Windsor, New Jersey, and Ringaskiddy, Cork, significantly increase the global capacities of the CDMO (contract development and manufacturing organization) for spray drying for pharma applications and improve the sites' capabilities.

Hovione to Sell iMAX Business, Reports Site Inspections

Hovione Announces Appointment of Colin Minchom as Vice President, Particle Design Business Unit

Colin Minchom Appointed VP Particle Design BU at Hovione

Hovione Wins Flumethasone Patent Case

Hovione’s Sales Grow 15% in FY 2010

Hovione Scientists Bring PAT and Inhalation Expertise To USP